President & CEO of $CACI Sells 33 Shares in Insider Sale

sold $CACI stock 4 times in the past 6 months, with 0 purchases and 4 sales recorded. Among these transactions, Representative Gilbert Ray Cisneros, Jr. sold up to $50,000 on 04/08, while Representative Kelly Morrison conducted 3 sales worth up to $45,000 on 03/20.

On the analyst front, Wall Street analysts have recently issued their reports on $CACI, with 7 firms providing buy ratings and 0 offering sell ratings. Stifel, UBS, Truist Securities, William Blair, Barclays, Wells Fargo, and Jefferies are among the firms that have endorsed buying shares of $CACI in the past year.

Regarding price targets, multiple analysts have put forth their predictions for $CACI in the last 6 months, with a median target of $544. Recent targets include Noah Poponak from Goldman Sachs at $544.0 on 08/13, Gavin Parsons from UBS at $614.0 on 08/08, Jonathan Siegmann from Stifel at $600.0 on 08/08, Sheila Kahyaoglu from Jefferies at $535.0 on 08/06, Tobey Sommer from Truist Securities at $550.0 on 07/24, David Strauss from Barclays at $510.0 on 04/29, and Matthew Akers from Wells Fargo at $513.0 on 04/28.

Institutional investors have also shown interest in $CACI, with 293 adding shares to their portfolios and 366 reducing positions in the most recent quarter. Close Asset Management Ltd added 324,531 shares, Citadel Advisors LLC added 255,369 shares, AllianceBernstein L.P. added 232,834 shares, Boston Partners added 197,880 shares, while Westwood Holdings Group Inc, Wellington Management Group LLP, and Proficio Capital Partners LLC decreased their shares in the second quarter of 2025.

This information serves as a snapshot of the recent activities surrounding $CACI, providing insights into insider trading, hedge fund activity, congressional stock trading, analyst ratings, and price targets for the company. Investors and stakeholders alike can leverage this data to make informed decisions about their involvement with $CACI in the ever-evolving financial landscape.